Tal Zvi Zaks Moderna, Inc. (MRNA) insider trading activity

Tal Zvi Zaks is Chief Medical Officer of Moderna, Inc.. Currently has a direct ownership of 0 shares of MRNA, which is worth approximately $0. The most recent transaction as insider was on Dec 28, 2020, when has been sold 1,200 shares (Common Stock) at a price of $115.52 per share, resulting in proceeds of $138,624. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Tal Zvi Zaks Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 28 2020	SELL Open market or private sale	$138,624 $115.52 p/Share	1,200 Reduced 100.0%	0 Common Stock
Dec 28 2020	BUY Exercise of conversion of derivative security	$25,116 $20.93 p/Share	1,200 Added 50.0%	1,200 Common Stock
Dec 21 2020	SELL Open market or private sale	$2,440,882 $142.5 p/Share	17,129 Reduced 100.0%	0 Common Stock
Dec 21 2020	BUY Exercise of conversion of derivative security	$298,558 $17.43 p/Share	17,129 Added 50.0%	17,129 Common Stock
Dec 14 2020	SELL Open market or private sale	$3,965,886 $158.42 p/Share	25,034 Reduced 100.0%	0 Common Stock
Dec 14 2020	BUY Exercise of conversion of derivative security	$416,315 $16.63 p/Share	25,034 Added 50.0%	25,034 Common Stock
Dec 07 2020	SELL Open market or private sale	$3,171,600 $158.58 p/Share	20,000 Reduced 100.0%	0 Common Stock
Dec 07 2020	BUY Exercise of conversion of derivative security	$289,000 $14.45 p/Share	20,000 Added 50.0%	20,000 Common Stock
Nov 30 2020	SELL Open market or private sale	$2,964,000 $148.2 p/Share	20,000 Reduced 100.0%	0 Common Stock
Nov 30 2020	BUY Exercise of conversion of derivative security	$303,800 $15.19 p/Share	20,000 Added 50.0%	20,000 Common Stock
Nov 23 2020	SELL Open market or private sale	$1,503,150 $100.21 p/Share	15,000 Reduced 100.0%	0 Common Stock
Nov 23 2020	BUY Exercise of conversion of derivative security	$235,200 $15.68 p/Share	15,000 Added 50.0%	15,000 Common Stock
Nov 16 2020	SELL Open market or private sale	$1,453,050 $96.87 p/Share	15,000 Reduced 100.0%	0 Common Stock
Nov 16 2020	BUY Exercise of conversion of derivative security	$235,200 $15.68 p/Share	15,000 Added 50.0%	15,000 Common Stock
Nov 09 2020	SELL Open market or private sale	$1,175,250 $78.35 p/Share	15,000 Reduced 100.0%	0 Common Stock
Nov 09 2020	BUY Exercise of conversion of derivative security	$235,200 $15.68 p/Share	15,000 Added 50.0%	15,000 Common Stock
Nov 02 2020	SELL Open market or private sale	$1,012,350 $67.49 p/Share	15,000 Reduced 100.0%	0 Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$235,200 $15.68 p/Share	15,000 Added 50.0%	15,000 Common Stock
Oct 26 2020	SELL Open market or private sale	$1,053,150 $70.21 p/Share	15,000 Reduced 100.0%	0 Common Stock
Oct 26 2020	BUY Exercise of conversion of derivative security	$235,200 $15.68 p/Share	15,000 Added 50.0%	15,000 Common Stock
Oct 19 2020	SELL Open market or private sale	$1,087,800 $72.52 p/Share	15,000 Reduced 100.0%	0 Common Stock
Oct 19 2020	BUY Exercise of conversion of derivative security	$235,200 $15.68 p/Share	15,000 Added 50.0%	15,000 Common Stock
Oct 12 2020	SELL Open market or private sale	$1,115,550 $74.37 p/Share	15,000 Reduced 100.0%	0 Common Stock
Oct 12 2020	BUY Exercise of conversion of derivative security	$235,200 $15.68 p/Share	15,000 Added 50.0%	15,000 Common Stock
Oct 05 2020	SELL Open market or private sale	$1,058,100 $70.54 p/Share	15,000 Reduced 100.0%	0 Common Stock

Also insider at

ADAP

Adaptimmune Therapeutics PLC Healthcare

Director

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD Healthcare

TZZ

Tal Zvi Zaks

Chief Medical Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account